21
Symposia
/ Preliminary Scientific Programme
WFSBP 2017
T43: SCHIZOPHRENIA: BASIC/CLINICAL
S-16
08:30–10:00
The elephant in the room: The role of glial cells in
psychiatric disorders
Chair:
Sabina Berretta, USA
Co-Chair: Mikhail Pletnikov, USA
S-16-001
Psychiatric genetic risk factors in healthy and diseased
astrocytes
Mikhail Pletnikov, USA
S-16-002
Glia-extracellular matrix interactions in the pathophysi-
ology of schizophrenia and Bipolar Disorder (BD)
Sabina Berretta, USA
S-16-003
Abnormalities of glutamate transporter localization in
severe mental illness
Robert McCullumsmith, USA
S-16-004
Evidence for neuroinflammation, gliosis and leaky brain
in people with schizophrenia
Cyndi Shannon Weickert, Australia
T43: SCHIZOPHRENIA: BASIC/CLINICAL
S-17
08:30–10:00
Psychosis is disrespectful to diagnostic boundaries:
Nosological and pathobiological implications of
psychoses beyond the schizophrenia spectrum
Chair:
John Waddington, Ireland
Co-Chair: Peter Buckley, USA
S-17-001
Reconciling the diversity of psychotic illness and dimen-
sional concepts with current diagnostic algorithms
Rajiv Tandon, USA
S-17-002
Psychosis in major depressive disorder: Systematic com-
parisons with and beyond the schizophrenia spectrum
John Waddington, Ireland
S-17-003
Psychosis in Bipolar Disorder (BP): Genetics and rela-
tionships to paternal age
Peter Buckley, USA
J. Waddington
S-17-004
Post-stroke psychosis: Pathobiology and behavioral
susceptibility
Eileen Joyce, United Kingdom
T49: SUICIDE: BASIC/CLINICAL
S-18
08:30–10:00
Epigenetic modification, effect of early life stress, and
signaling mechanisms in suicide
Chair:
Ghanshyam Pandey, USA
Co-Chair: Victoria Arango, USA
S-18-001
Impact of the early-life environment on the epigenetic
regulation of the anterior cingulate gyrus
Gustavo Turecki, Canada
S-18-002
Expression and methylation of glucocorticoid receptors
and FKBP5 in teenage and adult suicide
Ghanshyam Pandey, USA
S-18-003
Genome-wide epigenetic changes in suicide attempters
Jussi Jokinen, Sweden
S-18-004
5-HT1A receptor anti-apoptotic transduction pathways
in suicide
Victoria Arango, USA
T11: DEPRESSION: BASIC/CLINICAL
S-19
08:30–10:00
Psychedelics: Mechanisms and applications in
psychiatry
Chair:
Tomas Palenicek, Czech Republic
Co-Chair: Franz X. Vollenweider, Switzerland
S-19-001
Role of 5-HT2A receptors in the mechanism of action
of psilocybin and LSD and the treatment of affective
disorders
Franz X. Vollenweider, Switzerland
S-19-002
The effect of psilocybin on brain connectivity and emo-
tional processing in healthy volunteers
Tomas Palenicek, Czech Republic
S-19-003
Psilocybin for the treatment of depression
Robin Carhart-Harris, United Kingdom
MON